Catastrophic Antiphospholipid Syndrome (CAPS) is a rare, severe autoimmune disease causing rapid-onset, widespread blood clotting and multi-organ failure. Prompt diagnosis and aggressive treatment are crucial for survival.
Platelet Disorders
Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is an autoimmune disorder that increases the risk of blood clots, pregnancy complications, and other health problems. Early diagnosis and management are crucial.
Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary Hemorrhagic Telangiectasia (HHT) is a rare genetic disorder causing abnormal blood vessels, leading to frequent nosebleeds and internal bleeding.
Lipoprotein(a): The Silent Heart Risk You Need to Know
Lp(a): genetic risk for clots & heart disease. Not lowered by diet. Tests measure levels. Manage other risk factors.
Pulmonary Embolism (PE)
A pulmonary embolism (PE) is a life-threatening blockage in lung arteries, often from a leg clot. Urgent diagnosis and treatment are vital.
HELLP Syndrome
HELLP syndrome: A serious pregnancy issue with hemolysis, elevated liver enzymes, and low platelets. Requires urgent care.
Platelet Aggregation Test (PAT)
Platelet aggregation test: Checking how blood cells clump to form clots using different agonists.
Physiology of Hemostasis
Hemostasis is the remarkable biological process that keeps our blood flowing within the confines of our vascular network.
Platelet
From their role in wound healing to their potential for causing harm, platelets are a captivating paradox.
Manual APTT Mixing Studies
Manual APTT mixing studies involve mixing patient plasma with normal plasma or specific factor concentrates to differentiate factor deficiencies from inhibitors
Thrombotic Thrombocytopenic Purpura (TTP) & ADAMTS13
Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening blood disorder that causes blood clots to form throughout the body.
Activated Partial Thromboplastin Time (aPTT) Blood Test
The APTT assay measures how long it takes for a blood clot to form by measuring the amount of time it takes for fibrinogen to be converted to fibrin.